Related Experiment Video
Updated: Jul 27, 2026

MicroRNA Expression Profiles of Human iPS Cells, Retinal Pigment Epithelium Derived From iPS, and Fetal Retinal Pigment Epithelium
Published on: June 24, 2014
Identification and analysis of diverse programmed cell death patterns in idiopathic pulmonary fibrosis using
1Department of Respiration, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Programmed cell death (PCD) plays a key role in idiopathic pulmonary fibrosis (IPF). New signatures, PCDI.prog and PCDI.diag, can predict IPF progression and aid in early diagnosis.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Biomarker Discovery
Background:
- Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by fibrotic tissue replacement, leading to respiratory failure.
- The exact cause of IPF is unknown, but programmed cell death (PCD) is increasingly recognized as a significant factor in its development and progression.
- PCD affects both alveolar epithelial cells and immune cells within the fibrotic lung environment, highlighting its complex role in IPF pathogenesis.
Purpose of the Study:
- To investigate programmed cell death (PCD) patterns in idiopathic pulmonary fibrosis (IPF) for novel diagnostic and prognostic applications.
- To identify and analyze diverse PCD patterns using advanced sequencing techniques.
- To develop predictive and diagnostic signatures for IPF based on identified PCD-related genes.
Main Methods:
- Utilized microarray-based transcriptome profiling and single-nucleus RNA sequencing to analyze PCD patterns in IPF.
- Identified IPF-related genes through differential expression analysis, Cox regression, and specialized bioinformatics programs ('Scissor', 'Findmarkers').
- Employed machine learning algorithms to construct stable predictive and diagnostic signatures for IPF.
Main Results:
- Developed a stable PCDI.prog signature using 101 machine learning techniques, demonstrating high efficacy in predicting IPF patient outcomes across multiple datasets.
- Integration of the PCDI.prog signature with clinical data (age, gender, GAP score) allows for prediction of disease progression and survival.
- An additional PCDI.diag signature was identified, offering potential for early IPF diagnosis.
Conclusions:
- The PCDI.prog and PCDI.diag signatures provide valuable insights for the early diagnosis and prognostic assessment of IPF.
- These signatures represent a novel approach for personalized treatment strategies in IPF patients.
- Further research into PCD patterns can significantly advance the understanding and management of IPF.
More Related Videos
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
11:44Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Related Concept Videos
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...